KR102226310B1 - Saccharomyces cerevisiae FT4-1 strain producing beta-glucan and not producing biogenic amine isolated from blueberry and uses therof - Google Patents
Saccharomyces cerevisiae FT4-1 strain producing beta-glucan and not producing biogenic amine isolated from blueberry and uses therof Download PDFInfo
- Publication number
- KR102226310B1 KR102226310B1 KR1020190111896A KR20190111896A KR102226310B1 KR 102226310 B1 KR102226310 B1 KR 102226310B1 KR 1020190111896 A KR1020190111896 A KR 1020190111896A KR 20190111896 A KR20190111896 A KR 20190111896A KR 102226310 B1 KR102226310 B1 KR 102226310B1
- Authority
- KR
- South Korea
- Prior art keywords
- strain
- alcohol
- glucan
- saccharomyces cerevisiae
- yeast
- Prior art date
Links
- 150000001412 amines Chemical class 0.000 title claims abstract description 30
- 230000000035 biogenic effect Effects 0.000 title claims abstract description 30
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 title claims abstract description 25
- 229920002498 Beta-glucan Polymers 0.000 title claims abstract description 25
- 240000004808 Saccharomyces cerevisiae Species 0.000 title abstract description 63
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 title abstract description 63
- 240000000851 Vaccinium corymbosum Species 0.000 title description 11
- 235000003095 Vaccinium corymbosum Nutrition 0.000 title description 11
- 235000017537 Vaccinium myrtillus Nutrition 0.000 title description 11
- 235000021014 blueberries Nutrition 0.000 title description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 88
- 238000004519 manufacturing process Methods 0.000 claims abstract description 54
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000014101 wine Nutrition 0.000 claims abstract description 21
- 102000006995 beta-Glucosidase Human genes 0.000 claims abstract description 19
- 108010047754 beta-Glucosidase Proteins 0.000 claims abstract description 19
- 108010046334 Urease Proteins 0.000 claims abstract description 17
- 235000021107 fermented food Nutrition 0.000 claims abstract description 14
- 239000007858 starting material Substances 0.000 claims abstract description 13
- 241000235070 Saccharomyces Species 0.000 claims description 11
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 10
- 235000021028 berry Nutrition 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 229960001340 histamine Drugs 0.000 claims description 5
- 229960003732 tyramine Drugs 0.000 claims description 5
- 230000028327 secretion Effects 0.000 claims description 4
- 230000003248 secreting effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 29
- 239000002609 medium Substances 0.000 description 28
- 238000000855 fermentation Methods 0.000 description 23
- 230000004151 fermentation Effects 0.000 description 23
- 239000007788 liquid Substances 0.000 description 23
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
- 239000008103 glucose Substances 0.000 description 21
- 239000000243 solution Substances 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 244000005700 microbiome Species 0.000 description 11
- 235000013305 food Nutrition 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 230000010261 cell growth Effects 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 108020004463 18S ribosomal RNA Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 235000019216 blueberry extract Nutrition 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 229940055416 blueberry extract Drugs 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000005779 cell damage Effects 0.000 description 3
- 208000037887 cell injury Diseases 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000007222 ypd medium Substances 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000120652 Cellulomonas sp. Species 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000194105 Paenibacillus polymyxa Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000205160 Pyrococcus Species 0.000 description 1
- 241000205156 Pyrococcus furiosus Species 0.000 description 1
- 241000030064 Saccharomyces cerevisiae NRRL Y-12632 Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000187420 Streptomyces reticuli Species 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- 101800000970 Vacuolating cytotoxin Proteins 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003627 anti-cholesterol Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 229960004642 ferric ammonium citrate Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- -1 isoflavone glycosides Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G1/00—Preparation of wine or sparkling wine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/76—Yeasts
- A23V2250/762—Saccharomyces
-
- C12R1/865—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
본 발명은 블루베리로부터 분리된 베타-글루칸을 생성하고, 바이오제닉 아민을 생산하지 않는 사카로마이세스 세레비지애 FT4-1 균주 및 이의 용도에 관한 것이다.The present invention relates to a Saccharomyces cerevisiae FT4-1 strain that produces beta-glucan isolated from blueberries and does not produce biogenic amines, and uses thereof.
우리나라는 고대로부터 식품의 제조에 사용되는 발효기술과 숙성기술이 발달해 왔고, 이에 따라 발효기술을 이용한 전통주도 지속적으로 개발되고 있다. 전통주는 제조방법에 따라 크게 전통 증류주와 전통 발효주로 나누어지며, 특히 전통 발효주는 첨가된 재료에 따라 맛과 향이 독특하고 각기 개성적인 기능성을 함유하고 있다.Since ancient times, fermentation technology and aging technology used in food production have been developed in Korea, and accordingly, traditional liquor using fermentation technology is continuously being developed. Traditional liquor is largely divided into traditional distilled liquor and traditional fermented liquor according to the manufacturing method. In particular, traditional fermented liquor has a unique taste and aroma depending on the ingredients added, and each contains unique functionality.
전통주의 발효에는 사카로마이세스(Saccharomyces) 속, 아스퍼질러스(Aspergillus) 속, 바실러스(Bacillus) 속, 락토바실러스(Lactobacillus) 속 등의 균주들이 사용되고 있는데, 최근에는 발효 재료와 더불어 이와 같은 발효 균주들이 발효과정 중에 생산하는 부산물의 효능 및 특성을 강조한 건강 기능성 발효주가 생산되고 있다.There fermentation of traditionalism include saccharide as MY access (Saccharomyces) genus Aspergillus (Aspergillus) genus Bacillus (Bacillus) genus Lactobacillus bacteria (Lactobacillus) in such strains have been used, in recent years, with fermented material such fermentation strain Healthy functional fermented liquor is being produced that emphasizes the efficacy and characteristics of by-products produced during the fermentation process.
발효과정에서 발효 미생물들에 의해 생산되는 것 중 하나인 감마-아미노뷰티르산(γ-amino butyric acid, GABA)은 자연계에 분포하는 비단백질성 아미노산의 일종으로 뇌나 척수와 같은 중추신경계의 주된 억제성 신경전달물질(inhibitory neurotransmitter)로 알려져 있다. 뇌의 혈류를 활발하게 하고 뇌에 산소 공급량을 증가시켜 뇌세포의 대사기능을 촉진시키며, 혈액 내의 중성지방을 줄이고 간기능을 개선시키는 등의 여러 약리 활성으로 인해, 뇌동맥 휴유증에 의한 두통, 귀 울림, 의욕저하 등의 치료제에 응용되어 왔다. 또한, 고혈압과 같은 성인병 등의 예방 및 개선에 효과적인 것으로 밝혀져, 기능성 식품소재로서의 관심이 고조되고 있고 최근에는 감마-아미노뷰티르산을 다량 함유하는 음료가 출시되기도 했다.Gamma-amino butyric acid (GABA), one of the products produced by fermentation microorganisms during fermentation, is a type of non-proteinaceous amino acid distributed in nature and has a major inhibitory effect on the central nervous system such as the brain and spinal cord. It is known as an inhibitory neurotransmitter. Due to various pharmacological activities such as activating blood flow to the brain and increasing oxygen supply to the brain to promote metabolic function of brain cells, reducing triglycerides in the blood and improving liver function, headaches and ringing in the ears caused by cerebral artery dystrophy , It has been applied to treatments such as decreased motivation. In addition, it has been found to be effective in preventing and improving adult diseases such as hypertension, and interest as a functional food material is increasing, and recently, beverages containing a large amount of gamma-aminobutyric acid have been released.
한편, 바이오제닉 아민(biogenic amine)은 인체에서 성장조절 및 염증조절, 신경전달 등의 생리적 기능을 담당하지만, 인체의 분해 한도를 넘어서는 바이오제닉 아민을 식품을 통해서 섭취하는 경우에는 유해한 증상이 나타난다. 따라서 발효에 있어서, 발효과정 동안 바이오제닉 아민을 생산하지 않는 발효 균주의 선발이 매우 중요하다.On the other hand, biogenic amines are responsible for physiological functions such as growth control, inflammation control, and neurotransmission in the human body, but harmful symptoms appear when biogenic amines that exceed the human body's decomposition limit are consumed through food. Therefore, in fermentation, it is very important to select a fermentation strain that does not produce biogenic amines during the fermentation process.
와인과 같은 베리류의 알코올 발효에는 다양한 미생물들이 관여하고 있으며 복잡한 화학적 단계를 반복하면서 미생물들 간 다양한 작용을 통해 이루어진다. 많은 해외 국가에서는 와인의 제조를 위하여 사카로마이세스 세레비지애를 스타터 균주로 사용하여 와인의 품질 향상을 도모하고 있으며, 알코올 발효능이 우수하고 와인 제조 시 품질 향상에 도움이 되는 효모의 선별에 많은 노력을 기울이고 있다.Various microorganisms are involved in alcohol fermentation of berries such as wine, and it is achieved through various actions between microorganisms while repeating complex chemical steps. Many foreign countries use Saccharomyces cerevisiae as a starter strain for wine production to improve the quality of wine. I'm putting a lot of effort into it.
한편, 한국등록특허 제1599271호에서는 '베리류 과실로부터 분리된 알코올을 생산하고 바이오제닉 아민을 생산하지 않는 사카로마이세스 세레비지애 BA42 균주 및 이의 용도'가 개시되어 있고, 한국등록특허 제1599270호에서는 '오디로부터 분리된 알코올을 생산하고 바이오제닉 아민을 생산하지 않는 사카로마이세스 세레비지애 BA33 균주 및 이의 용도'가 개시되어 있으나, 본 발명의 '블루베리로부터 분리된 베타-글루칸을 생성하고, 바이오제닉 아민을 생산하지 않는 사카로마이세스 세레비지애 FT4-1 균주 및 이의 용도'에 대해서는 아직까지 개시된 바가 전혀 없다.On the other hand, Korean Patent Registration No. 1599271 discloses'Saccharomyces cerevisiae BA42 strain that produces alcohol isolated from berries and does not produce biogenic amines and uses thereof', and Korean Patent No. 1599270 In the'Saccharomyces cerevisiae BA33 strain that produces alcohol isolated from Audi and does not produce biogenic amines and uses thereof' is disclosed, but'beta-glucan isolated from blueberries is produced and , Saccharomyces cerevisiae FT4-1 strain that does not produce biogenic amine and its use has not been disclosed at all.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명에서는 블루베리 및 이의 엑기스로부터 알코올, 당 및 아황산에 대한 내성이 있고, β-글루칸(β-glucan) 생성능, 알코올 생성능 및 β-글루코시다제(β-glucosidase) 분비능이 있으며, 바이오제닉 아민 및 우레아제를 생성하지 않는 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-1 균주를 분리하였다. 본 발명의 사카로마이세스 세레비지애 FT4-1 균주는 와인 제조를 위한 스타터 균주 등 발효식품 관련 산업에 다양하게 사용이 가능함을 확인함으로써, 본 발명을 완성하였다.The present invention was derived from the above requirements, and in the present invention, it has resistance to alcohol, sugar and sulfurous acid from blueberries and its extract, and β-glucan production ability, alcohol production ability and β-glucosida Saccharomyces cerevisiae (Saccharomyces cerevisiae) FT4-1 strain that has the ability to secrete β-glucosidase and does not produce biogenic amines and ureases was isolated. The present invention was completed by confirming that the Saccharomyces cerevisiae FT4-1 strain of the present invention can be used in a variety of industries related to fermented foods such as a starter strain for wine production.
상기 과제를 해결하기 위해, 본 발명은 알코올, 당 및 아황산에 대한 내성이 있고, β-글루칸(β-glucan) 생성능, 알코올 생성능 및 β-글루코시다제(β-glucosidase) 분비능이 있으며, 바이오제닉 아민 및 우레아제를 생성하지 않는 사카로마이세스 세레비지애(Saccharomyces cerevisae) FT4-1 균주(KCCM12519P)를 제공한다.In order to solve the above problems, the present invention has resistance to alcohol, sugar and sulfurous acid, has β-glucan production ability, alcohol production ability and β-glucosidase secretion ability, and is biogenic. It provides a Saccharomyces cerevisae FT4-1 strain (KCCM12519P) that does not produce amines and ureases.
또한, 본 발명은 상기 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 알코올 생산용 조성물을 제공한다.In addition, the present invention provides a composition for alcohol production comprising the strain, a culture solution thereof, a concentrate of the culture solution, or a dried product thereof as an active ingredient.
또한, 본 발명은 상기 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 발효식품 제조용 스타터(starter) 조성물을 제공한다.In addition, the present invention provides a starter composition for producing fermented food comprising the strain, a culture solution thereof, a concentrate of the culture solution, or a dried product thereof as an active ingredient.
본 발명의 베리류 과실로부터 분리된 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-1 균주는 알코올, 당 및 아황산에 대한 내성이 있고, β-글루칸(β-glucan) 생성능, 알코올 생성능 및 β-글루코시다제(β-glucosidase) 분비능이 있으며, 바이오제닉 아민 및 우레아제를 생성하지 않으므로, 와인 제조를 위한 스타터 균주 등 발효식품 관련 산업에 매우 유용하게 이용될 수 있을 것으로 기대된다. Saccharomyces cerevisiae FT4-1 strain isolated from the berries of the present invention is resistant to alcohol, sugar and sulfurous acid, and β-glucan production ability, alcohol production ability and β- Since it has the ability to secrete glucosidase (β-glucosidase) and does not produce biogenic amines and ureases, it is expected to be very useful in fermented food related industries such as starter strains for wine production.
도 1은 본 발명에서 분리한 사카로마이세스 세레비지애(Saccharomyces cerevisae) FT4-1 균주(KCCM12519P)의 18S rRNA의 염기서열을 나타낸 것이다.
도 2는 본 발명에서 분리한 사카로마이세스 세레비지애(Saccharomyces cerevisae) FT4-1 균주(KCCM12519P)의 계통도를 나타낸 것이다.
도 3은 본 발명에서 분리한 사카로마이세스 세레비지애(Saccharomyces cerevisae) FT4-1 균주(KCCM12519P)의 배양시간에 따른 에탄올 생성량, 건조 균체량 및 흡광도를 측정한 결과이다. A: 2% 글루코오스 함유 YPD 액체배지에 배양한 결과, B: 24% 글루코오스 함유 YPD 액체배지에 배양한 결과, ●: 흡광도(660nm), ■: 에탄올 함량, ○: 건조세포무게.
도 4는 본 발명에서 분리한 사카로마이세스 세레비지애(Saccharomyces cerevisae) FT4-1 균주(KCCM12519P)의 에탄올, 당 및 아황산 내성을 분석한 결과이다. 다양한 농도의 에탄올, 당 및 아황산을 포함하는 YPD 배지에서 30℃ 및 200 rpm 조건으로 35시간 배양 후 건조세포중량(g/L)으로 사카로마이세스 세레비지애의 에탄올, 당 및 아황산 내성을 A, B 및 C 그래프로 나타내었다. Figure 1 shows the nucleotide sequence of the 18S rRNA of the Saccharomyces cerevisae (Saccharomyces cerevisae) FT4-1 strain (KCCM12519P) isolated in the present invention.
Figure 2 shows the schematic diagram of the Saccharomyces cerevisae (Saccharomyces cerevisae) FT4-1 strain (KCCM12519P) isolated in the present invention.
3 is a result of measuring the amount of ethanol produced, the amount of dry cells, and the absorbance according to the culture time of the Saccharomyces cerevisae FT4-1 strain (KCCM12519P) isolated in the present invention. A: As a result of culturing on YPD liquid medium containing 2% glucose, B: As a result of culturing on YPD liquid medium containing 24% glucose, ●: absorbance (660 nm), ■: ethanol content, ○: dry cell weight.
Figure 4 is a result of analysis of ethanol, sugar and sulfurous acid resistance of the Saccharomyces cerevisae (Saccharomyces cerevisae) FT4-1 strain (KCCM12519P) isolated in the present invention. After incubation for 35 hours at 30°C and 200 rpm in YPD medium containing various concentrations of ethanol, sugar and sulfurous acid, the ethanol, sugar and sulfurous acid resistance of Saccharomyces cerevisiae was tested by dry cell weight (g/L) , B and C graphs.
본 발명의 목적을 달성하기 위하여, 본 발명은 알코올, 당 및 아황산에 대한 내성이 있고, β-글루칸(β-glucan) 생성능, 알코올 생성능 및 β-글루코시다제(β-glucosidase) 분비능이 있으며, 바이오제닉 아민 및 우레아제를 생성하지 않는 사카로마이세스 세레비지애(Saccharomyces cerevisae) FT4-1 균주(KCCM12519P)를 제공한다.In order to achieve the object of the present invention, the present invention is resistant to alcohol, sugar and sulfurous acid, has β-glucan production ability, alcohol production ability and β-glucosidase secretion ability, It provides a Saccharomyces cerevisae FT4-1 strain (KCCM12519P) that does not produce biogenic amines and ureases.
본 발명에서는 전라북도 순창군에서 재배 및 수확한 블루베리 및 이의 엑기스로부터 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주들을 분리하였고, 그 중 알코올, 당 및 아황산에 대한 내성이 있고, β-글루칸(β-glucan) 생성능, 알코올 생성능 및 β-글루코시다제(β-glucosidase) 분비능이 있으며, 바이오제닉 아민 및 우레아제를 생성하지 않는 사카로마이세스 세레비지애 균주를 분리·동정하였으며, 이를 사카로마이세스 세레비지애 FT4-1 균주로 명명하여 한국미생물보존센터에 2019년 05월 03일자로 기탁하였다(기탁번호: KCCM12519P). In the present invention, Saccharomyces cerevisiae strains were isolated from blueberries cultivated and harvested in Sunchang-gun, Jeollabuk-do, and extracts thereof, among which are resistant to alcohol, sugar and sulfurous acid, and β-glucan (β -glucan) production ability, alcohol production ability and β-glucosidase secretion ability, and the Saccharomyces cerevisiae strain, which does not produce biogenic amines and ureases, was isolated and identified. It was named as Cerevisiae FT4-1 strain and deposited with the Korea Microbial Conservation Center on May 03, 2019 (Accession No.: KCCM12519P).
본 발명의 일 구현 예에 따른 균주에서, 상기 바이오제닉 아민은 히스타민(histamine) 또는 티라민(tyramine)일 수 있으나, 이에 제한되지 않는다. 상기 알코올 내성은 8~20% 에탄올에 대한 내성이며, 당 내성은 3~50% 글루코오스에 대한 내성이며, 아황산 내성은 100~300 ppm의 아황산에 대한 내성이다.In the strain according to an embodiment of the present invention, the biogenic amine may be histamine or tyramine, but is not limited thereto. The alcohol resistance is resistance to 8-20% ethanol, sugar resistance is resistance to 3-50% glucose, and sulfurous acid resistance is resistance to sulfurous acid of 100 to 300 ppm.
또한, 본 발명은 상기 균주 또는 이의 배양액을 유효성분으로 포함하는 알코올 생산용 조성물을 제공한다.In addition, the present invention provides a composition for alcohol production comprising the strain or a culture medium thereof as an active ingredient.
본 발명의 일 구현 예에 따른 조성물에서, 상기 알코올은 과실류를 발효시킨 알코올일 수 있으며, 가장 바람직하게는 베리류를 발효시킨 와인일 수 있으나, 이에 제한되지 않는다.In the composition according to an embodiment of the present invention, the alcohol may be an alcohol fermented fruits, most preferably wine fermented berries, but is not limited thereto.
본 발명의 균주를 배양하는 방법은 당업계에 통상적으로 이용되는 방법에 따라 배양할 수 있으며, 특별한 방법에 한정되는 것은 아니다.The method of culturing the strain of the present invention may be cultured according to a method commonly used in the art, and is not limited to a specific method.
본 발명의 균주를 배양하는 단계에서 얻어지는 상기 균주 또는 상기 균주의 배양물 또는 상기 균주의 배양액의 농축액을 첨가제로 사용할 경우, 상기 균주 또는 상기 균주의 배양물 또는 상기 균주의 배양액의 농축액을 그대로 첨가하거나 다른 첨가제를 함께 사용할 수 있으며, 통상적인 방법에 따라 적절하게 사용될 수 있다 유효 성분의 혼합양은 그의 사용 목적에 따라 적합하게 결정될 수 있다.When the strain obtained in the step of culturing the strain of the present invention or the culture product of the strain or the concentrate of the culture solution of the strain is used as an additive, the strain or the culture product of the strain or the concentrate of the culture solution of the strain is added as it is, or Other additives may be used together, and may be appropriately used according to a conventional method. The mixing amount of the active ingredient may be suitably determined according to the purpose of use thereof.
또한, 본 발명은 상기 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 발효식품 제조용 스타터(starter) 조성물을 제공한다.In addition, the present invention provides a starter composition for producing fermented food comprising the strain, a culture solution thereof, a concentrate of the culture solution, or a dried product thereof as an active ingredient.
본 발명에 있어서, 발효식품 제조용 스타터(starter)란 발효식품 제조를 위해 발효에 관여하는 미생물을 포함하는 제제 또는 조성물을 의미한다. 발효식품 제조 시에 첨가함으로써 발효된 식품에서 생장할 수 있는 미생물 또는 우점종으로 생장할 수 있는 미생물을 제공하기 위하여 사용된다. 상기 식품 발효용 스타터를 사용하여 식품을 제조하는 경우, 상기 식품 발효용 스타터에 포함된 미생물에 의하여, 식품의 품질을 일정하게 조절하거나, 특정한 목적, 일 예로 식품에서 이취를 발생시키지 않거나, 감소시키는 목적을 달성할 수 있다. 본 발명에서는 사카로마이세스 세레비지애 FT4-1 균주 또는 이의 배양액을 스타터 균주로 이용함으로써, β-글루칸, 알코올 및 β-글루코시다제(β-glucosidase)를 포함하며, 바이오제닉 아민 및 우레아제는 포함하지 않는 발효 식품을 제조할 수 있다.In the present invention, the starter for fermented food production means a preparation or composition containing microorganisms involved in fermentation for the production of fermented food. It is used to provide microorganisms that can grow in fermented foods or as dominant species by adding them in the manufacture of fermented foods. In the case of manufacturing food using the food fermentation starter, by the microorganisms included in the food fermentation starter, the quality of the food is constantly controlled, or for a specific purpose, for example, to prevent or reduce off-flavor in food. You can achieve your purpose. In the present invention, by using Saccharomyces cerevisiae FT4-1 strain or a culture solution thereof as a starter strain, β-glucan, alcohol and β-glucosidase are included, and biogenic amines and ureases are Fermented foods that do not contain can be manufactured.
본 발명의 일 구현 예에 따른 발효식품 제조용 스타터 조성물에서, 상기 발효식품은 과실류를 발효시킨 발효주일 수 있고, 바람직하게는 베리류를 발효시킨 와인일 수 있으나, 이에 제한되지 않는다.In the starter composition for manufacturing fermented food according to an embodiment of the present invention, the fermented food may be a fermented wine fermented with fruits, preferably wine fermented with berries, but is not limited thereto.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by examples. However, the following examples are merely illustrative of the present invention, and the contents of the present invention are not limited to the following examples.
재료 및 방법Materials and methods
효모 분리 및 배양조건Yeast separation and culture conditions
다양한 효모를 분리하기 위해 전라북도 순창군에서 재배 및 수확한 블루베리 및 이의 엑기스를 구매 사용하였다. 증균을 위하여 250㎖의 YPD(효모추출물 1%, 펩톤 2%, 글루코오스 2%) 액체배지에 블루베리 또는 블루베리 엑기스를 5% 넣고 30℃에서 2일간 발효하여 분리에 이용하였다. 증균시킨 블루베리 및 블루베리 엑기스 발효물 10㎖을 균질화시킨 다음 90㎖의 멸균생리식염수에 넣어 십진법으로 희석하였고, 세균의 생장을 억제하기 위해 100㎍/㎖의 클로람페니콜을 함유한 YPD(효모추출물 1%, 펩톤 2%, 글루코오스 3%) 고체배지에 도말하여 30℃에서 2일간 배양하였다. 순수한 효모 콜로니를 분리하기 위해, 단일 콜로니를 분리하였고, YPD 액체배지에서 30℃에서 2일간 배양하였다. 효모 균주 중 알코올을 생성하여 발효에 적합한 효모를 선별하였고, 20%의 글리세롤을 포함한 YPD 액체배지에 혼합하여 -80℃에서 보관하였다. 균주의 활성화는 YPD 액체배지에서 30℃에서 2일간 배양하여 활성화시킨 후에 사용하였다.In order to separate various yeasts, blueberries grown and harvested in Sunchang-gun, Jeollabuk-do, and extracts thereof were purchased and used. For enrichment, 5% of blueberry or blueberry extract was added to 250 ml of YPD (
알코올 발효성 효모의 분리Isolation of alcohol fermentable yeast
가스 생성능은 듀람 시험을 통하여 확인하였다. 선별된 균주의 배양을 위해 효모는 YPD 액체배지에서 30℃, 24시간 동안 교반하여 배양하였다. 배양액의 2%는 20%의 글루코오스를 함유한 YPD 액체배지 10㎖을 포함하는 듀람관에 접종하였다. 이후 교반 없이 30℃에서 모든 듀람 시험관은 48시간 동안 배양하고, 48시간 후 가스 생성여부를 확인하여 1차 선별하였고, 1차 선별 효모들을 24% 글루코오스가 함유된 YPD 액체배지에 접종하여 48시간 배양후 배양액을 원심분리하여 배양 상등액을 취해 0.45㎛ 시린지 필터를 이용하여 필터한 뒤 하기 표 1에 따른 조건에 따라 HPLC를 이용해 알코올 생성능을 분석하였다. The gas generation ability was confirmed through the Duram test. For cultivation of the selected strain, the yeast was cultured by stirring at 30° C. for 24 hours in YPD liquid medium. 2% of the culture was inoculated into a Duram tube containing 10 ml of YPD liquid medium containing 20% glucose. Afterwards, all Duram test tubes were incubated at 30°C for 48 hours without agitation, and after 48 hours, the first screening was performed by checking whether gas was produced, and the first screening yeasts were inoculated into YPD liquid medium containing 24% glucose and cultured for 48 hours. After the culture was centrifuged, the culture supernatant was taken, filtered using a 0.45 μm syringe filter, and the alcohol production ability was analyzed using HPLC according to the conditions in Table 1 below.
(Agilent Technologies, Santa Clara, CA, USA)Agilent 1200 series
(Agilent Technologies, Santa Clara, CA, USA)
(Agilent Technologies, Santa Clara, CA, USA)Agilent 1200 series
(Agilent Technologies, Santa Clara, CA, USA)
(Bio-Rad, Hercules, CA, USA) Aminex HPX 87H column, 300 Х 7.8 mm
(Bio-Rad, Hercules, CA, USA)
바이오제닉 아민 생성 여부 확인Check whether biogenic amines are produced
선별 분리주의 바이오제닉 아민 생성 여부 조사는 YPD 액체배지에 각 분리주를 접종한 후 30℃, 150 rpm으로 24시간 진탕배양하여 전배양한 후 배양액 1㎖을 티라민 및 히스타민의 전구체 아미노산인 티로신 및 히스티딘이 0.1% 포함된 YPD 액체배지 9㎖에 접종하고 30℃, 150rpm으로 48시간 동안 진탕배양하여 본배양하였다. 본배양액은 13,000rpm에서 30분간 원심분리하여 균체를 제거하고, 균체가 제거된 배양 상등액을 바이오제닉아민 분석을 위한 시료로 사용하였다. 시료 용액과 표준 용액을 각각 0.5㎖ 취한 후 0.25㎖ 1,7-디아미노헵탄, 0.25㎖ 포화 Na2CO3 용액, 1% 아세톤 및 0.4㎖ 단실 클로라이드를 혼합한 후 45℃에서 1시간 동안 유도체화하였다. 유도체화 한 시료에 10% 프롤린(Sigma-aldrich)을 0.25㎖ 가한 후 잔량의 단실 클로라이드를 제거한 뒤 2.5㎖의 에틸에테르를 가하여 3분간 진탕한 후, 분리된 상등액을 취하여 증발시키고 남은 잔사를 0.5 ㎖의 아세토니트릴에 정용하여 0.45㎛ 시린지 필터(Sartorius)로 여과하여 분석에 사용하였다. 바이오제닉 아민 분석을 위한 기기 분석 조건은 상기 표 1과 같다.To investigate the production of biogenic amines of the selected isolates, after inoculating each isolate in YPD liquid medium, shake culture at 30°C and 150 rpm for 24 hours before incubation. Inoculated into 9 ml of YPD liquid medium containing 0.1%, and cultured with shaking at 30° C. and 150 rpm for 48 hours, followed by main culture. The main culture solution was centrifuged at 13,000 rpm for 30 minutes to remove the cells, and the culture supernatant from which the cells were removed was used as a sample for biogenic amine analysis. After taking 0.5 ml each of the sample solution and the standard solution, 0.25
우레아제 생성여부확인Confirmation of urease production
유해효소인 우레아제(urease)의 생성여부는 우레아 신속 테스트 키트(MB cell, Korea)를 이용하여 확인하였다. 우레아 신속 테스트 키트에 선별 균주를 접종하고 바세린 오일(vaseline oil)을 첨가하여 산소가 차단된 상태로 37℃에서 24시간동안 배양하였고 4시간 간격으로 색 변화를 관찰하여 우레아제 생성여부를 확인하였다. The production of urease, a harmful enzyme, was confirmed using a urea rapid test kit (MB cell, Korea). The selected strain was inoculated into the urea rapid test kit, and vaseline oil was added to incubate at 37° C. for 24 hours in an oxygen-blocked state, and color changes were observed at 4 hour intervals to confirm whether or not urease was produced.
β-글루코시다제 효소활성β-glucosidase enzyme activity
β-글루코시다제(β-glucosidase) 효소활성을 분석하기 위해 1.0% 에스쿨린(esculin)과 0.5% 페릭 암모늄 시트레이트(ferric ammonium citrate)를 첨가하여 제조한 YPD 고체배지에 분리주를 접종하여 37℃에서 24시간 배양한 후 콜로니 주변에 생기는 검정색 투명환의 유무에 따라 β-글루코시다제 효소활성을 조사하였다. In order to analyze β-glucosidase enzyme activity, the isolate was inoculated into YPD solid medium prepared by adding 1.0% esculin and 0.5% ferric ammonium citrate to 37°C. After incubation for 24 hours, β-glucosidase enzyme activity was investigated according to the presence or absence of black transparent rings around the colonies.
선별 효모의 동정 및 계통수 작성Identification of selected yeast and preparation of phylogenetic tree
최종적으로 선별 균주 중에서 베리류 와인 발효에 적합한 효모 FT4-1를 선별하였으며, 선별 균주를 동정하기 위해 DNA를 추출하여 18S rRNA 유전자를 분석하여 (주)마크로젠에 의뢰하여 동정하였다. 염기서열은 ExTaxone-e 서버(http://www.eztaxon.org)를 통해 표준 균주의 염기서열을 확보하여 MEGA 6.0 프로그램을 사용하여 염기서열 간 상호 비교 후 계통도를 작성하였다. 계통도는 Neighbor-joining 알고리즘을 사용하였으며, 1,000회 반복으로 부트스트랩(bootstrapping)하여 작성한 계통도의 견고성을 확인하였다. Finally, the yeast FT4-1 suitable for fermentation of berries wine was selected from among the selected strains, and DNA was extracted to identify the selected strain, and the 18S rRNA gene was analyzed and identified by requesting Macrogen Co., Ltd. As for the base sequence, the base sequence of the standard strain was secured through the ExTaxone-e server (http://www.eztaxon.org), and a systematic diagram was prepared after mutual comparison between base sequences using the MEGA 6.0 program. For the tree, the neighbor-joining algorithm was used, and the robustness of the generated tree was confirmed by bootstrapping it with 1,000 iterations.
선별 효모의 β-글루칸(β-glucan) 함량 분석Analysis of β-glucan content in selected yeast
최종 선별된 FT4-1 균주의 β-글루칸(β-glucan) 함량을 조사하기 위하여 YPD 액체배지에서 30℃ 및 150rpm으로, 48시간 동안 진탕배양하였고, 3,000rpm으로 원심분리하여 분리된 균체를 증류수로 3회 세척하고 동결 건조한 시료를 분석에 이용하였다. β-글루칸 함량은 효모 β-글루칸 키트(K-YBGL, Megazyme International Ireland Ltd.)를 이용하여 측정하였다.In order to investigate the β-glucan content of the finally selected FT4-1 strain, the cells were cultured with shaking at 30° C. and 150 rpm for 48 hours in YPD liquid medium, and centrifuged at 3,000 rpm with distilled water. Washed three times and freeze-dried samples were used for analysis. The β-glucan content was measured using a yeast β-glucan kit (K-YBGL, Megazyme International Ireland Ltd.).
선별 효모의 균체 성장 및 알코올 생성능Cell growth and alcohol production ability of selected yeast
최종 선별된 FT4-1 균주의 배양시간에 따른 균체 및 알코올 생성능 분석을 위하여 액체배지에 선별한 효모를 접종하여 30℃ 및 150rpm으로 2일간 진탕배양하여 알코올 생성과 균체 성장의 조사를 위한 전배양을 실시하였다. 알코올 생성능 조사를 위한 배지는 24% 글루코오스가 함유된 YPD 액체배지를 사용하였고, 균체성장 조사를 위한 배지는 2% 글루코오스가 함유된 YPD 액체배지를 사용하였으며, 각 액체배지에 전배양액 2%를 접종한 후 30℃, 200rpm에서 36시간 동안 배양하였다. 시간에 따른 균체 성장 및 알코올 생성능 조사를 위하여 2시간 단위로 시료를 취하여 건조 균체량, 알코올 생산능 및 흡광도를 측정하였다. 건조 균체량의 측정을 위하여 10㎖의 배양액을 3,000rpm에서 20분간 원심분리한 후 분리된 균체를 증류수로 3회 세척하고 80℃에서 항량이 될 때까지 건조시킨 후 무게를 측정하였다. 건조 균체량과 비교를 위한 흡광도의 측정은 1㎖의 배양액을 회수하여 3,000rpm에서 20분간 원심분리한 후 증류수에 3회 세척하고 멸균 증류수 1㎖에 재부유하여 660nm에서 자외선/가시광선 분광광도계(UV/VIS spectrophotometer, SPECORD 200, Analytik Jena, Germany)를 사용하여 흡광도를 측정하고 기록하였다. 상기 표 1에 따른 조건 하에 HPLC 분석을 통해 알코올 생산량을 측정하였고, 모든 실험구는 3회 반복 실험을 통 하여 평균값을 이용하였다.In order to analyze the cell and alcohol production ability according to the culture time of the finally selected FT4-1 strain, the selected yeast was inoculated in a liquid medium and cultured with shaking at 30°C and 150 rpm for 2 days to conduct pre-culture for investigation of alcohol production and cell growth. Implemented. YPD liquid medium containing 24% glucose was used as the medium for the investigation of alcohol production ability, YPD liquid medium containing 2% glucose was used as the medium for cell growth investigation, and 2% of the pre-culture solution was inoculated into each liquid medium. Then, it was incubated at 30° C. and 200 rpm for 36 hours. In order to investigate the cell growth and alcohol production ability according to time, samples were taken every 2 hours and the dry cell mass, alcohol production ability, and absorbance were measured. In order to measure the amount of dried cells, 10 ml of the culture solution was centrifuged at 3,000 rpm for 20 minutes, and the separated cells were washed three times with distilled water, dried at 80° C. to a constant weight, and then the weight was measured. To measure the absorbance for comparison with the amount of dry cells, collect 1 ml of the culture solution, centrifuge at 3,000 rpm for 20 minutes, wash three times in distilled water, resuspend in 1 ml of sterile distilled water, /VIS spectrophotometer, SPECORD 200, Analytik Jena, Germany) was used to measure and record the absorbance. Alcohol production was measured through HPLC analysis under the conditions according to Table 1, and the average value was used for all experimental groups through repeated experiments three times.
알코올 내성, 당내성, 아황산 내성 조사Alcohol tolerance, sugar tolerance, sulfurous acid tolerance investigation
최종 선별된 FT4-1 균주의 알코올 내성을 조사하기 위하여 0, 8, 14 및 20%의 무수에탄올을 YPD 액체배지에 효모를 접종한 후 바로 첨가하였다. 건조 균체량은 30℃에서 72시간 동안 배양하여 조사하였다. 당 내성은 3, 30, 40 및 50%의 글루코오스를 함유한 YPD 액체배지에 30℃에서 48시간 동안 효모를 배양한 후 건조 균체량을 측정하여 조사하였다. 아황산 내성은 100, 200, 300 ppm의 메타중아황산칼륨을 첨가한 YPD 액체배지에서 30℃에서 48시간 동안 배양하여 건조 균체량을 측정하였다.In order to investigate the alcohol tolerance of the finally selected FT4-1 strain, 0, 8, 14, and 20% of anhydrous ethanol were added immediately after inoculating the yeast in the YPD liquid medium. The dry cell mass was investigated by incubating at 30° C. for 72 hours. Sugar tolerance was investigated by culturing the yeast for 48 hours at 30° C. in YPD liquid medium containing 3, 30, 40 and 50% glucose, and then measuring the amount of dry cells. Sulfurous acid resistance was incubated at 30° C. for 48 hours in a YPD liquid medium to which 100, 200, and 300 ppm of potassium metabisulfite was added, and the amount of dried cells was measured.
실시예 1. 블루베리 및 블루베리 엑기스로부터 알코올 발효성 효모의 분리Example 1. Isolation of alcohol fermentable yeast from blueberries and blueberry extract
와인과 같은 베리류의 알코올 발효에는 다양한 미생물이 관여하고 있으며 복잡한 화학적 단계를 반복하면서 미생물들 간 다양한 작용을 통해 이루어진다. 많은 해외 국가에서는 와인의 제조를 위하여 사카로마이세스 세레비지애(S. cerevisiae)를 스타터로 사용하여 와인의 품질 향상을 도모하고 있으며, 알코올 발효능이 우수하고 와인 제조 시 품질 향상에 도움이 되는 효모의 선별에 많은 노력을 기울이고 있다. 따라서 효모 균주의 분리를 위하여 블루베리 및 블루베리 엑기스로부터 약 300여 종의 효모 분리주를 선별하였고, 선별 분리주는 다음 연구의 진행을 위해 -80℃에 보관하여 사용하였다. Various microorganisms are involved in alcohol fermentation of berries such as wine, and it is achieved through various actions between microorganisms while repeating complex chemical steps. In many foreign countries, S. cerevisiae is used as a starter for wine production to improve the quality of wine. A lot of effort is being put into the selection of yeast. Therefore, about 300 kinds of yeast isolates were selected from blueberries and blueberry extracts for the isolation of yeast strains, and the selected isolates were stored at -80°C for the next study.
선별한 분리주를 대상으로 알코올 발효능이 우수한 효모의 1차 선별을 위하여 듀람 튜브 테스트(durham tube test)를 통하여 가스 생성능을 조사하였고, 가스를 형성하는 균주를 1차로 선별하였다. 하지만 보고에 따르면 대부분의 효모들은 식별 가능한 가스 형성능 없이도 알코올을 생성하는 역할을 수행하기 때문에 추가적으로 HPLC 분석을 통하여 알코올 생성 여부를 조사하였고 그 결과 최종적으로 5% 이상의 알코올 생성능을 갖는 5종의 효모를 선별하였다(표 2). For the first screening of yeast having excellent alcohol fermentation ability for the selected isolates, gas-generating ability was investigated through a Durham tube test, and strains forming gas were first selected. However, according to reports, most of the yeasts play a role in producing alcohol without any identifiable gas-forming ability, so additionally, HPLC analysis was conducted to determine whether alcohol was produced, and as a result, five yeasts with an alcohol-producing ability of 5% or more were finally selected. (Table 2).
실시예 2. 바이오제닉 아민 비생성 효모의 선별Example 2. Selection of non-biogenic amine-producing yeast
앞서 선별한 5종의 효모를 대상으로 바이오제닉 아민인 히스타민 및 티라민의 생성 여부를 조사하였다. 대조구로는 균주를 접종하지 않은 YPD 액체배지를 사용하였으며, 결과는 하기 표 3에 개시한 바와 같이 최종 5종의 선별 균주 중 히스타민 및 티라민을 모두 생성하지 않는 균주는 FT4-1로 확인되었고, 대부분의 균주에서는 2종의 바이오제닉 아민이 검출되었지만 정량이 되지 않는 미비한 수치를 나타내었다. 따라서 앞선 알코올 발효능 및 바이오제닉 아민 생성 여부 결과를 토대로 베리류를 이용한 와인 제조에 적합한 효모로 FT4-1 균주를 선정하였다.The production of biogenic amines, histamine and tyramine, was investigated for the previously selected five yeasts. As a control, a YPD liquid medium without inoculation of the strain was used, and the results were identified as FT4-1, the strain that did not produce both histamine and tyramine among the final five selected strains, as disclosed in Table 3 below. In the strain of, two kinds of biogenic amines were detected, but were not quantified. Therefore, the FT4-1 strain was selected as a yeast suitable for wine production using berries based on the above results of alcohol fermentation ability and biogenic amine production.
포함 YPD 배지0.1% precursor
Containing YPD medium
결과는 3번 측정하였으며 표준편차로 표기하였음.The results were measured 3 times and expressed as standard deviation.
a N.D. - 검출되지 않음. a ND-not detected.
b N.Q. - 정량되지 않음. b NQ-not quantified.
실시예 3. 우레아제(Urease) 생성여부확인Example 3. Confirmation of urease production
세포손상을 주는 기전으로 헬리코박터 파일로리(Helicobacter pylori) 감염 시 우레아제에 의해 생성되는 암모니아(ammonia)에 의해 세포 손상이 생기고, 헬리코박터 파일로리의 분비 독소인 Vac A(vacuolating cytotoxin gene A)에 의해 상피세포의 공포화가 발생하는데 호중구에서 분비된 염증매개물질과 활성 산소화물에 의해서도 세포가 손상된다. 상피세포의 손상은 세포의 위축성 변화를 일으키고 세포손상에 대한 보상기전으로 세포증식이 증가하며 활발하게 증식하는 세포는 발암물에 의하여 유전자가 손상을 받을 기회가 많아진다. 따라서 우레아제 생성 여부를 확인하기 위한 실험을 진행하였고, 측정 결과 FT4-1, FT4-7 및 FT4-140 균주에서 우레아제가 생성되지 않음을 확인하였다(표 4). Cell damage is caused by ammonia produced by urease during Helicobacter pylori infection as a mechanism of cell damage, and epithelial cells are vacuolated by vacuolating cytotoxin gene A (Vac A), a secreted toxin of Helicobacter pylori. Upset occurs, and cells are also damaged by inflammatory mediators and free radicals secreted from neutrophils. Damage to epithelial cells causes atrophic change of cells, increases cell proliferation as a compensatory mechanism for cell damage, and cells that proliferate actively have a greater chance of damaging genes by carcinogens. Therefore, an experiment was conducted to determine whether urease was produced, and as a result of the measurement, it was confirmed that urease was not produced in the FT4-1, FT4-7, and FT4-140 strains (Table 4).
실시예 4. β-글루코시다제 효소활성Example 4. β-glucosidase enzyme activity
β-글루코시다제(β-glucosidase)는 비배당체의 형성과 이소플라본 배당체의 가수분해에 필요한 촉매작용을 한다고 알려져 있다. β-글루코시다제를 생산하는 미생물로는 아스퍼질러스 나이거(Aspergillus niger), 트라이코더마 레제이(Trichoderma reesei), 푸사리움 옥시스포룸(Fusarium oxysporum) 등의 곰팡이와 사카로마이세스 세레비지애(Saccharomyces cerevisiae), 스키조사카로마이세스 폼베(Schizosaccharoyces pombe) 등의 효모 그리고 토양세균으로 스트렙토마이세스 레티쿨리(Streptomyces reticuli), 바실러스 서틸리스(Bacillus subtilis), 바실러스 폴리믹사(Bacillus polymyxa), 바실러스 서큘란스(Bacillu circulans), 아그로박테리움 튜머파시엔스(Agrobacterium tumefaciens), 셀룰로모나스 종(Cellulomonas sp.) CS1-1 및 초고온성 고세균인 피로코커스 푸리오수스(Pyrococcus furiosus) 등 다양한 계통군에 속하는 균주들이 알려져 있고, 이들이 생산하는 β-글루코시다제에 대한 효소학적 특성과 유전자도 다수 밝혀졌다. 전통발효식품에 주로 존재하는 대두 이소플로본 배당체인 제니스틴과 다이드진의 체내 흡수를 위해 비배당체 형태로 전환하는 생물전환 공정에 활용가능성을 갖는 β-글루코시다제 활성을 확인한 결과, FT4-1 균주의 β-글루코시다제의 활성이 가장 우수한 것으로 확인되었다(표 5).β-glucosidase is known to act as a catalyst for the formation of non-glycosides and hydrolysis of isoflavone glycosides. Microorganisms that produce β-glucosidase Fungi such as Aspergillus niger , Trichoderma reesei , Fusarium oxysporum and Saccharomyces cerevisiae , Schizocaromyces Pombe ( Schizosaccharoyces pombe ) In yeast and soil bacteria such as Streptomyces retina Cooley (Streptomyces reticuli), Bacillus standing subtilis (Bacillus subtilis), Bacillus poly miksa (Bacillus polymyxa), Bacillus circulator lance (Bacillu circulans), Agrobacterium tyumeo Pacific Enschede (Agrobacterium tumefaciens), and cellulose Pseudomonas species (Cellulomonas sp.) CS1-1 and high temperature property of archaea Pyrococcus Puri's sewage (Pyrococcus furiosus), etc. are known strains belonging to different clade, they produce β- glucosidase for which A number of enzymatic properties and genes were also revealed. As a result of confirming the activity of β-glucosidase, which has the potential to be utilized in the bioconversion process of converting genistine and daidgin, which are mainly present in traditional fermented foods to non-glycoside form for absorption in the body, FT4-1 strain It was confirmed that the activity of β-glucosidase was the most excellent (Table 5).
실시예 5. 효모의 동정 및 계통수 작성Example 5. Identification of yeast and preparation of phylogenetic tree
선별 균주 FT4-1의 동정을 위해 NS1 및 NS8 프라이머를 이용해 유전자를 증폭하여 18S rRNA 유전자 염기서열을 분석하였다. 분석한 결과를 바탕으로 GenBank에서 BLAST 검색 결과 사카로마이세스 세레비지애(S. cerevisiae)로 판명되었으며, 염기서열은 서열번호 1과 같다(도 1). 염기서열을 이용하여 SeqMatch program에서 상동성 높은 표준균주와 상호비교를 실시하였다. 18S rRNA 유전자 염기서열을 토대로 하여 계통수를 작성하여 계통수를 분석한 결과, 사카로마이세스 세레비지애 NRRL Y-12632와 가장 가까운 근연관계로 확인되었다(도 2). 최종적으로 선별된 균주를 사카로마이세스 세레비지애 FT4-1 균주로 명명하였고, 2019년 05월 03일자로 한국미생물보존센터(KCCM)에 기탁하여 기탁번호 KCCM12519P를 부여받았다.For the identification of the selected strain FT4-1, the genes were amplified using NS1 and NS8 primers, and the sequence of the 18S rRNA gene was analyzed. Based on the analysis result, the BLAST search result in GenBank was found to be S. cerevisiae , and the nucleotide sequence is shown in SEQ ID NO: 1 (FIG. 1). The nucleotide sequence was used to perform cross-comparison with the standard strain having high homology in the SeqMatch program. As a result of analyzing the phylogenetic tree by creating a phylogenetic tree based on the 18S rRNA gene sequence, it was found to be the closest closely related to Saccharomyces cerevisiae NRRL Y-12632 (FIG. 2). The finally selected strain was named Saccharomyces cerevisiae FT4-1 strain, and was deposited with the Korea Microbial Conservation Center (KCCM) on May 03, 2019, and was given the deposit number KCCM12519P.
실시예 6. β-글루칸 함량 분석Example 6. β-glucan content analysis
피부 생리활성 물질 중 하나인 β-글루칸(β-glucan)은 글루코오스가 β-(1-3)-D-글리코사이드 결합으로 연결되어 있는 균일 다당류이며, 효모 세포벽의 가장 많은 양의 구성성분으로 효모 세포벽에서 추출된다. β-글루칸은 항암, 항콜레스테롤, 면역증강 및 피부 재생 등과 같은 여러 가지 생리활성 촉진효과가 있다고 보고되어 건강식품 첨가물로서 이용이 증가되고 있다. 특히, 효모로부터 얻어지는 β-글루칸은 피부를 보호하고 손상 시 피부를 재생시키는 역할을 하며, 인체 내에서 면역시스템을 강화시키는데 중요한 역할을 하는 것으로 알려져 있다. 또한, β-(1,3)- 또는 β-(1,6)- 결합의 분자구조 보다 β-(1,3)-/β(1-6)-결합의 분자구조를 갖는 β-글루칸이 생리활성 촉진이 우수하다고 알려져 있다. 사카로마이세스 세레비지애 FT4-1 균주에서 생산된 효모 균체의 β-글루칸 함량을 측정한 결과, 세포건조무게(g) 당 21.76 mg으로 확인되었다(표 6).One of the skin physiologically active substances, β-glucan, is a homogeneous polysaccharide in which glucose is linked by β-(1-3)-D-glycoside bonds, and yeast is the largest component of the yeast cell wall. It is extracted from the cell wall. β-glucan has been reported to have various physiological activities promoting effects such as anti-cancer, anti-cholesterol, immunity enhancement and skin regeneration, and thus its use as a health food additive is increasing. In particular, β-glucan obtained from yeast protects the skin and plays a role in regenerating the skin in case of damage, and is known to play an important role in strengthening the immune system in the human body. In addition, β-glucan having a molecular structure of β-(1,3)-/β(1-6)-bonds than that of β-(1,3)- or β-(1,6)- bonds It is known to be excellent in promoting physiological activity. As a result of measuring the β-glucan content of yeast cells produced in Saccharomyces cerevisiae FT4-1 strain, it was found to be 21.76 mg per dry cell weight (g) (Table 6).
실시예 7. 선별 균주의 균체성장 및 알코올 발효능Example 7. Cell growth and alcohol fermentation ability of the selected strain
사카로마이세스 세레비지애 FT4-1 균주를 2% 글루코오스를 함유한 YPD 액체배지에 배양하였을 때 배양시간에 따른 에탄올 생성량, 흡광도 및 건조 균체량(dried cell weight)의 변화를 조사하였다. 그 결과, 도 3A에 개시한 바와 같이 균체의 성장단계 중 유도기(log phase)가 4~12시간이었으며 정지기(stationary phase)는 16~20시간이었다. 배양기간 중 균체량은 24시간에서 3.9183g/L으로 최대 증가하였고 이후 균체량이 서서히 증가하거나 감소하는 형태인 사멸기(death phase)를 나타내었다. 흡광도의 경우도 마찬가지로 균체량 결과와 동일한 형태를 나타내었다. 배양기간 중 알코올 함량은 20시간에 가장 높은 알코올 생성량(0.8324%)을 나타내었으며, 여기에서 알코올의 생성량은 기본적으로 당 대사 과정 중 탄소원의 함량에 의해 알코올 생성량이 좌우되기 때문에 최소한의 2% 글루코오스 함유 배지에서는 높은 수치를 보이지는 않았다고 판단된다. 따라서 알코올 발효능의 경우에 11mg/mL의 알코올을 생성한다고 보고된 24% 글루코오스가 첨가된 YPD 액체배지를 사용하여 조사하였다. 그 결과, 배양기간 중 32시간에서 생산된 알코올은 11.4424%로 최대 알코올 생산량을 보였으며 이후 서서히 감소하였다. 균체량은 기본 생장 배지(2% 글루코오스 함유 YPD 배지)에서 배양(3.9183g/L)하였을 때보다 약 3배 증가한 11.9956g/L의 균체량을 나타내었다(도 3B). When the Saccharomyces cerevisiae FT4-1 strain was cultured in YPD liquid medium containing 2% glucose, changes in ethanol production amount, absorbance, and dried cell weight according to culture time were investigated. As a result, as disclosed in Fig. 3A, the log phase of the cell growth phase was 4 to 12 hours and the stationary phase was 16 to 20 hours. During the incubation period, the cell mass increased to 3.9183 g/L at the maximum at 24 hours, and thereafter, the cell mass showed a death phase in the form of gradually increasing or decreasing. In the case of absorbance, the same form as the cell mass result was also shown. The alcohol content during the incubation period showed the highest alcohol production amount (0.8324%) in 20 hours, and the alcohol production amount basically depends on the amount of alcohol produced by the carbon source during the sugar metabolism process, so it contains at least 2% glucose. It is judged that the medium did not show high levels. Therefore, in the case of alcohol fermentation ability, it was investigated using YPD liquid medium added with 24% glucose, which was reported to produce 11 mg/mL of alcohol. As a result, alcohol produced at 32 hours during the incubation period was 11.4424%, showing the maximum alcohol production, and then gradually decreased. The amount of cells exhibited a cell weight of 11.9956 g/L, which was about 3 times higher than when cultured in the basic growth medium (YPD medium containing 2% glucose) (3.9183 g/L) (Fig. 3B).
실시예 8. 선별 균주의 알코올 내성, 당 내성 및 아황산 내성Example 8. Alcohol resistance, sugar resistance and sulfurous acid resistance of selected strains
사카로마이세스 세레비지애 균주의 종균 배양은 아로마틱 향기 성분의 생산과 아황산 및 알코올 내성의 증가로 인해 일반적으로 사용되는 대표 알코올 발효용 균주이다. 알코올, 당, 아황산 저항성은 특히 포도 와인의 제조시 고농도의 글루코오스와 알코올 및 아황산이 첨가됨으로 와인 제조를 위한 효모로서는 필수적인 요소 중이다. 따라서, 베리류를 이용한 와인 제조를 위한 효모로서의 가능성을 확인하기 위하여 선별한 균주의 알코올, 당 및 아황산 내성을 조사하였다. FT4-1 균주의 알코올 내성의 조사를 위하여 0, 8, 14 및 20%의 무수 에탄올을 일반 효모 배양 배지인 YPD 액체배지에 각각 첨가하여 건조 균체량을 조사하여 내성여부를 확인하였다. 그 결과, 도 4A에 개시한 바와 같이 8%의 에탄올을 첨가한 실험구에서는 대조구(control, 4.96g/L)에 비하여 건조 균체량이 0.51g/L로 감소하였으나 생존가능함을 확인하였으며, 고농도 첨가구에서는 거의 생장하지 못하였다. 이는 초기 글루코오스와 알코올의 농도가 높을 경우 최종 바이오매스 농도는 낮다는 선행 연구 결과와 유사한 결과를 확인하였다. 하지만 알코올 내성에 대한 다른 문헌들과 비교하여 보아도 8% 이상의 농도에서는 잘 성장하지 못하므로 다른 연구 결과들과는 큰 차이를 보이지는 않았다.The seed culture of the Saccharomyces cerevisiae strain is a representative alcohol fermentation strain generally used due to the production of aromatic fragrance components and increased tolerance to sulfurous acid and alcohol. Resistance to alcohol, sugar, and sulfurous acid is an essential factor as a yeast for wine production, as high concentrations of glucose, alcohol, and sulfurous acid are added during the production of grape wine. Therefore, in order to confirm the possibility as a yeast for wine production using berries, the alcohol, sugar and sulfurous acid resistance of the selected strains were investigated. In order to investigate the alcohol tolerance of the FT4-1 strain, 0, 8, 14 and 20% of absolute ethanol were added to YPD liquid medium, which is a general yeast culture medium, respectively, and the amount of dry cells was investigated to confirm resistance. As a result, as disclosed in FIG. 4A, it was confirmed that the amount of dry cells was reduced to 0.51 g/L compared to the control (control, 4.96 g/L) in the experimental group to which 8% of ethanol was added, but it was viable. Almost did not grow. This confirmed a result similar to the results of previous studies that the final biomass concentration was low when the initial glucose and alcohol concentration was high. However, even when compared with other literature on alcohol tolerance, it did not grow well at concentrations above 8%, so there was no significant difference from other studies.
당 내성 결과, 대조구(control, 4.34g/L) 보다 30% 글루코오스를 첨가한 실험구에서 균체량이 10.37g/L로 약 2배 가량 크게 증가하였으며, 40% 및 50%의 글루코오스가 첨가된 실험구에서도 8.40g/L와 5.94g/L로 대조구보다 증가함을 나타내어 FT4-1 균주가 당 내성이 우수한 것을 확인하였다(도 4B). As a result of glucose tolerance, in the experimental group with 30% glucose added to the control group (control, 4.34 g/L), the cell mass increased approximately 2 times to 10.37 g/L, and the experimental group with 40% and 50% glucose added. Also, it was confirmed that the FT4-1 strain was excellent in glucose tolerance by showing an increase of 8.40 g/L and 5.94 g/L compared to the control (FIG. 4B).
아황산은 식품 및 음료와 약품의 보존의 용도로 첨가되는 물질로서 산화 방지 및 항균효과와 갈변효과 방지 등의 효과를 나타낸다. 따라서, 와인 제조에도 산화 방지와 선택적 유해 미생물 억제능을 위하여 사용되고 있어 효모는 와인제조를 위해 아황산 내성을 가질 필요성이 있다. 현재 국내 식품 규격상 350mg/L의 첨가 허용 규격에 맞추어 100, 200 및 300 ppm의 아황산을 첨가하여 FT4-1 균주의 아황산 내성을 조사하였다. 그 결과, 아황산 첨가에 따라 FT4-1 균주는 큰 영향을 받지 않고 생장하는 것을 확인함으로써 우수한 아황산 내성을 지닌 효모임을 확인하였다(도 4C).Sulfuric acid is a substance added for preservation of foods, beverages and medicines, and exhibits antioxidant, antibacterial and browning effects. Therefore, since it is used for preventing oxidation and inhibiting selective harmful microorganisms in wine production, there is a need for yeast to have sulfurous acid resistance for wine production. Sulfurous acid resistance of FT4-1 strain was investigated by adding 100, 200 and 300 ppm of sulfurous acid according to the current domestic food standard of 350mg/L. As a result, it was confirmed that the FT4-1 strain was not significantly affected by the addition of sulfurous acid, thereby confirming that it was a yeast having excellent resistance to sulfurous acid (FIG. 4C).
<110> Microbial Institute for Fermentation Industyry <120> Saccharomyces cerevisiae FT4-1 strain producing beta-glucan and not producing biogenic amine isolated from blueberry and uses therof <130> PN19263 <160> 1 <170> KoPatentIn 3.0 <210> 1 <211> 1688 <212> DNA <213> Saccharomyces cerevisiae <400> 1 tgtataagca atttatacag tgaaactgcg aatggctcat taaatcagtt atcgtttatt 60 tgatagttcc tttactacat ggtataactg tggtaattct agagctaata catgcttaaa 120 atctcgaccc tttggaagag atgtatttat tagataaaaa atcaatgtct tcggactctt 180 tgatgattca taataacttt tcgaatcgca tggccttgtg ctggcgatgg ttcattcaaa 240 tttctgccct atcaactttc gatggtagga tagtggccta ccatggtttc aacgggtaac 300 ggggaataag ggttcgattc cggagaggga gcctgagaaa cggctaccac atccaaggaa 360 ggcagcaggc gcgcaaatta cccaatccta attcagggag gtagtgacaa taaataacga 420 tacagggccc attcgggtct tgtaattgga atgagtacaa tgtaaatacc ttaacgagga 480 acaattggag ggcaagtctg gtgccagcag ccgcggtaat tccagctcca atagcgtata 540 ttaaagttgt tgcagttaaa aagctcgtag ttgaactttg ggcccggttg gccggtccga 600 ttttttcgtg tactggattt ccaacggggc ctttccttct ggctaacctt gagtccttgt 660 ggctcttggc gaaccaggac ttttactttg aaaaaattag agtgttcaaa gcaggcgtat 720 tgctcgaata tattagcatg gaataataga ataggacgtt tggttctatt ttgttggttt 780 ctaggaccat cgtaatgatt aatagggacg gtcgggggca tcagtattca attgtcagag 840 gtgaaattct tggatttatt gaagactaac tactgcgaaa gcatttgcca aggacgtttt 900 cattaatcaa gaacgaaagt taggggatcg aagatgatca gataccgtcg tagtcttaac 960 cataaactat gccgactagg gatcgggtgg tgttttttta atgacccact cggcacctta 1020 cgagaaatca aagtctttgg gttctggggg gagtatggtc gcaaggctga aacttaaagg 1080 aattgacgga agggcaccac caggagtgga gcctgcggct taatttgact caacacgggg 1140 aaactcacca ggtccagaca caataaggat tgacagattg agagctcttt cttgattttg 1200 tgggtggtgg tgcatggccg ttcttagttg gtggagtgat ttgtctgctt aattgcgata 1260 acgaacgaga ccttaaccta ctaaatagtg gtgctagcat ttgctggtta tccacttctt 1320 agagggacta tcggtttcaa gccgatggaa gtttgaggca ataacaggtc tgtgatgccc 1380 ttagacgttc tgggccgcac gcgcgctaca ctgacggagc cagcgagtct aaccttggcc 1440 gagaggtctt ggtaatcttg tgaaactccg tcgtgctggg gatagagcat tgtaattatt 1500 gctcttcaac gaggaattcc tagtaagcgc aagtcatcag cttgcgttga ttacgtccct 1560 gccctttgta cacaccgccc gtcgctagta ccgattgaat ggcttagtga ggcctcagga 1620 tctgcttaga gaagggggca actccatctc agagcggaga attggacgtc ccaacccata 1680 aggattga 1688 <110> Microbial Institute for Fermentation Industyry <120> Saccharomyces cerevisiae FT4-1 strain producing beta-glucan and not producing biogenic amine isolated from blueberry and uses therof <130> PN19263 <160> 1 <170> KoPatentIn 3.0 <210> 1 <211> 1688 <212> DNA <213> Saccharomyces cerevisiae <400> 1 tgtataagca atttatacag tgaaactgcg aatggctcat taaatcagtt atcgtttatt 60 tgatagttcc tttactacat ggtataactg tggtaattct agagctaata catgcttaaa 120 atctcgaccc tttggaagag atgtatttat tagataaaaa atcaatgtct tcggactctt 180 tgatgattca taataacttt tcgaatcgca tggccttgtg ctggcgatgg ttcattcaaa 240 tttctgccct atcaactttc gatggtagga tagtggccta ccatggtttc aacgggtaac 300 ggggaataag ggttcgattc cggagaggga gcctgagaaa cggctaccac atccaaggaa 360 ggcagcaggc gcgcaaatta cccaatccta attcagggag gtagtgacaa taaataacga 420 tacagggccc attcgggtct tgtaattgga atgagtacaa tgtaaatacc ttaacgagga 480 acaattggag ggcaagtctg gtgccagcag ccgcggtaat tccagctcca atagcgtata 540 ttaaagttgt tgcagttaaa aagctcgtag ttgaactttg ggcccggttg gccggtccga 600 ttttttcgtg tactggattt ccaacggggc ctttccttct ggctaacctt gagtccttgt 660 ggctcttggc gaaccaggac ttttactttg aaaaaattag agtgttcaaa gcaggcgtat 720 tgctcgaata tattagcatg gaataataga ataggacgtt tggttctatt ttgttggttt 780 ctaggaccat cgtaatgatt aatagggacg gtcgggggca tcagtattca attgtcagag 840 gtgaaattct tggatttatt gaagactaac tactgcgaaa gcatttgcca aggacgtttt 900 cattaatcaa gaacgaaagt taggggatcg aagatgatca gataccgtcg tagtcttaac 960 cataaactat gccgactagg gatcgggtgg tgttttttta atgacccact cggcacctta 1020 cgagaaatca aagtctttgg gttctggggg gagtatggtc gcaaggctga aacttaaagg 1080 aattgacgga agggcaccac caggagtgga gcctgcggct taatttgact caacacgggg 1140 aaactcacca ggtccagaca caataaggat tgacagattg agagctcttt cttgattttg 1200 tgggtggtgg tgcatggccg ttcttagttg gtggagtgat ttgtctgctt aattgcgata 1260 acgaacgaga ccttaaccta ctaaatagtg gtgctagcat ttgctggtta tccacttctt 1320 agagggacta tcggtttcaa gccgatggaa gtttgaggca ataacaggtc tgtgatgccc 1380 ttagacgttc tgggccgcac gcgcgctaca ctgacggagc cagcgagtct aaccttggcc 1440 gagaggtctt ggtaatcttg tgaaactccg tcgtgctggg gatagagcat tgtaattatt 1500 gctcttcaac gaggaattcc tagtaagcgc aagtcatcag cttgcgttga ttacgtccct 1560 gccctttgta cacaccgccc gtcgctagta ccgattgaat ggcttagtga ggcctcagga 1620 tctgcttaga gaagggggca actccatctc agagcggaga attggacgtc ccaacccata 1680 aggattga 1688
Claims (5)
A starter composition for producing fermented food comprising the strain of claim 1, a culture solution thereof, a concentrate of the culture solution, or a dried product thereof as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190111896A KR102226310B1 (en) | 2019-09-10 | 2019-09-10 | Saccharomyces cerevisiae FT4-1 strain producing beta-glucan and not producing biogenic amine isolated from blueberry and uses therof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190111896A KR102226310B1 (en) | 2019-09-10 | 2019-09-10 | Saccharomyces cerevisiae FT4-1 strain producing beta-glucan and not producing biogenic amine isolated from blueberry and uses therof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102226310B1 true KR102226310B1 (en) | 2021-03-11 |
Family
ID=75142833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190111896A KR102226310B1 (en) | 2019-09-10 | 2019-09-10 | Saccharomyces cerevisiae FT4-1 strain producing beta-glucan and not producing biogenic amine isolated from blueberry and uses therof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102226310B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100797152B1 (en) * | 2006-11-24 | 2008-01-23 | 고려대학교 산학협력단 | Method for scale-up production of saccharomyces serevisiae jul3 comprising abundant beta;-glucan |
KR20170127668A (en) * | 2016-05-12 | 2017-11-22 | 주식회사 글루칸 | Method for manufacturing of beta glucan Increased purity and yield |
KR101904164B1 (en) * | 2018-05-04 | 2018-10-04 | 재단법인 발효미생물산업진흥원 | Saccharomyces cerevisae SRCM100936 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof |
-
2019
- 2019-09-10 KR KR1020190111896A patent/KR102226310B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100797152B1 (en) * | 2006-11-24 | 2008-01-23 | 고려대학교 산학협력단 | Method for scale-up production of saccharomyces serevisiae jul3 comprising abundant beta;-glucan |
KR20170127668A (en) * | 2016-05-12 | 2017-11-22 | 주식회사 글루칸 | Method for manufacturing of beta glucan Increased purity and yield |
KR101904164B1 (en) * | 2018-05-04 | 2018-10-04 | 재단법인 발효미생물산업진흥원 | Saccharomyces cerevisae SRCM100936 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101904164B1 (en) | Saccharomyces cerevisae SRCM100936 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof | |
Brizuela et al. | Lactobacillus plantarum as a malolactic starter culture in winemaking: A new (old) player? | |
Maragkoudakis et al. | Biodiversity, dynamics and ecology of bacterial community during grape marc storage for the production of grappa | |
KR101788295B1 (en) | Fermentation method of wine by sequential inoculation of Lactobacillus plantarum JH287 followed by Saccharomyces cereivisiae cells | |
KR101422248B1 (en) | Issatchenkia orientalis ms-1 and its use | |
KR102267347B1 (en) | Acetobacter pasteurianus B7 and manufacturing method of fermented Kujippong vinegar using the same | |
KR102226280B1 (en) | Saccharomyces cerevisiae FT4-2 strain producing beta-glucan isolated from blueberry and uses therof | |
KR20140057092A (en) | Pichia anomala and brewed fermented alcohol made there with | |
KR102226310B1 (en) | Saccharomyces cerevisiae FT4-1 strain producing beta-glucan and not producing biogenic amine isolated from blueberry and uses therof | |
KR102088693B1 (en) | Saccharomyces cerevisae BA31 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof | |
KR102088696B1 (en) | Saccharomyces cerevisae BA34 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof | |
KR102226291B1 (en) | Saccharomyces cerevisiae FT4-3 strain producing beta-glucan isolated from blueberry and uses therof | |
KR101599271B1 (en) | Saccharomyces cerevisiae BA42 strain producing alcohol and nonproducing biogenic amine isolated from berry and uses therof | |
Roldán et al. | Use of Trichoderma enzymatic extracts on vinification of Palomino fino grapes in the sherry region | |
CN113519831B (en) | Fruit enzyme and preparation method thereof | |
CN113773977B (en) | Yeast strain with low ethanol yield and high aroma yield and application thereof | |
KR102409571B1 (en) | Method of manufacturing sweet flag vinegar using the barley nuruk and the sweet flag vinegar manufactured thereby | |
JP5904522B2 (en) | Microorganisms producing azasugar | |
Yao et al. | Growth capacity of Bacillus potential starter strains isolated from cocoa beans fermentation under culture stress conditions | |
KR20160060434A (en) | Flavour-enhancing yeast Saccharomyces cerevisiae and brewed alcohol made therewith | |
KR101599272B1 (en) | Saccharomyces cerevisiae B61 strain producing alcohol and gamma-aminobutyric acid and nonproducing biogenic amine isolated from vinegar of Rubus coreanus and uses therof | |
KR101591362B1 (en) | Saccharomyces cerevisiae M-5 strain producing alcohol and gamma-aminobutyric acid and nonproducing biogenic amine isolated from fermented liquid of raspberry and uses thereof | |
KR20220039942A (en) | Saccharomyces cerevisiae FT4-4 strain having antioxidant activity and tyrosinase inhibitory activity isolated from blueberry and uses thereof | |
CN116179405B (en) | Lactobacillus plantarum ZF617 and application thereof | |
KR101591361B1 (en) | Saccharomyces cerevisiae B-8 strain producing alcohol and gamma-aminobutyric acid and nonproducing biogenic amine isolated from fermented liquid of raspberry and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |